Versant Ventures' New Biotechnology Incubator, Blueline Bioscience, Announces
Collaboration in Canada
TORONTO, Nov. 20, 2013 /CNW/ - Blueline Bioscience, a Toronto-based biotech
incubator launched by Versant Ventures in September of this year, today
announced a collaboration with Celgene. Blueline Bioscience is headquartered
in the MaRS Discovery District of Toronto and works closely with leading
academic and medical research centers in Canada to develop, fund, and grow
early-stage biotechnology companies.
Upon launch of new enterprises by Blueline Bioscience in areas of joint
strategic interest such as oncology and inflammation, an affiliate of Celgene
Corporation will have certain option rights through the collaboration.
Stefan Larson, President of Blueline Bioscience and an
Entrepreneur-in-Residence with Versant Ventures, stated: "We're excited to be
tapping into a wealth of medical discoveries that we can work to translate
from the laboratory into biotechnology products and companies. With the
collaboration and option agreement now signed with Celgene, Blueline
Bioscience is uniquely positioned in the life sciences community in Ontario."
Blueline Bioscience is one of several efforts launched this year in Canada by
Versant Ventures, including the establishment of a Versant office, the launch
of an Inception Sciences drug discovery unit in Vancouver, and the execution
of a significant deal with Bayer through Inception Sciences. Stefan Larson,
a life sciences entrepreneur in Toronto, recently joined Versant as an
Entrepreneur-in-Residence and President of Blueline Bioscience. Several
Versant team members -- including Brad Bolzon, Ph.D., Jerel Davis, Ph.D., and
Gianni Gromo, M.D., Ph.D. -- will be engaged in launching new enterprises with
"Blueline Bioscience represents one of Versant's approaches to launching
early-stage biotechnology companies in Canada," said Brad Bolzon, Managing
Director at Versant Ventures. "We are very encouraged by the progress of the
Blueline Bioscience team in identifying promising academic programs and
launching such a strong collaboration. We look forward to growing and
developing additional start-ups in Toronto."
About Blueline Bioscience
Blueline Bioscience is a biotech incubator established by Versant Ventures in
Toronto, Canada. Headquartered in the MaRS Discovery District of Toronto,
Blueline Bioscience works with academic and medical researchers to translate
discoveries into early-stage biotechnology companies.
About Versant Ventures
Versant Ventures is a leading venture capital firm that invests in innovative,
groundbreaking bio-pharmaceuticals, medical devices, and other life science
opportunities. Founded in 1999, the firm consists of an experienced team
committed to helping entrepreneurs build successful companies that impact
healthcare and improve quality of life.
SOURCE Versant Ventures / Blueline Bioscience
Stefan Larson President Blueline Bioscience firstname.lastname@example.org
David Climie VP Communications Hill + Knowlton Strategies
To view this news release in HTML formatting, please use the following URL:
CO: Versant Ventures / Blueline Bioscience
NI: BTC VNT
-0- Nov/20/2013 13:00 GMT
Press spacebar to pause and continue. Press esc to stop.